Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
RespiStrong
- Development stage
- Unknown
- Lead developer
- Centaur Pharmaceuticals
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
RespiStrong is a pediatric probiotic supplement developed and marketed by Centaur Pharmaceuticals. It is formulated as a sachet containing a combination of two specific probiotic strains: Lactobacillus acidophilus NCFM and Bifidobacterium lactis Bi-07, delivering a total of 10 billion CFU. RespiStrong is designed to support respiratory immunity, gut health, and overall wellness in children. It is primarily indicated to reduce the frequency and severity of recurrent respiratory tract infections (RTIs) and allergic rhinitis by promoting the maturation of the immune system and stimulating innate and acquired immune responses. Additionally, it helps maintain healthy gut flora and manage symptoms of diarrhea and irritable bowel syndrome.
- Brand names
- RespiStrong
- Other names
- Lactobacillus acidophilus + Bifidobacterium lactisLactobacillus acidophilus NCFM + Bifidobacterium lactis Bi-07RespistrongRespistrong Orange and Vanilla SachetRespistrong SachetRespistrong Vanilla Orange Sachet
02
Targets
TLR (Toll-like receptors)
Beyond the preview
Go deeper on RespiStrong.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RespiStrong.